New diabetes clinical trial: A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose

Published on: January 18, 2023 at 11:00AM
Conditions:   Diabetes Mellitus, Type 2;   Healthy Participants
Interventions:   Drug: Semaglutide B, 1.34 mg/mL;   Drug: Semaglutide B, 0.68 mg/mL
Sponsor:   Novo Nordisk A/S
Not yet recruiting
https://ift.tt/o6ONPJw